Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug–drug interactions (DDIs). Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common.Purpose: The aim of the present stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qianmeng, Xie, Saili, Qiu, Xiangjun, Chen, Jingjing, Xu, Ren-Ai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502443/
https://www.ncbi.nlm.nih.gov/pubmed/31118708
http://dx.doi.org/10.2147/IDR.S199526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502443/
https://www.ncbi.nlm.nih.gov/pubmed/31118708
http://dx.doi.org/10.2147/IDR.S199526

Ejemplares similares